Cabaletta Bio Inc reports results for the quarter ended in September - Earnings Summary

Cabaletta Bio

10/11/2022 14:09

* Cabaletta Bio Inc  CABA.OQ  reported a quarterly adjusted
loss
of 39 cents​​ per share for the quarter ended in September. The
mean expectation of six analysts for the quarter was for a loss
of 48 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Cabaletta Bio Inc's reported EPS for the quarter was a
loss
of 39 cents​.
    * The mean earnings estimate of analysts had risen by
about 4.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Cabaletta Bio Inc shares had risen by 198.4% this
quarter and
lost 48.8% so far this year.
    * The company reported a quarterly loss of $11.43 million.
    * Wall Street's median 12-month price target for Cabaletta
Bio Inc
is $7.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 02:09 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.48          -0.39          Beat
 Jun. 30 2022      -0.50          -0.45          Beat
 Mar. 31 2022      -0.60          -0.45          Beat
 Dec. 31 2021      -0.60          -0.49          Beat